We are proud to share the latest scientific contribution of Alexis Denis, SVP Head of Drug Discovery and Marie Varin, Senior Scientist Medicinal Chemistry at Iktos, who have co-authored a newly published study in Cancer Letters uncovering promising therapeutic avenues for ATIP3-deficient breast cancers—an aggressive cancer subtype with limited treatment options and poor prognosis.
Follow the link to read the full publication.
